arXiv subjects

Vincenzo Patera

Publications and source records attributed to Vincenzo Patera.

12 recordsLinked to original sources

arXiv2026

Measurement of 80-200 MeV/n $^{16}$O nuclear cross-section on Carbon and Polyethylene targets with the nuclear emulsion detector of the FOOT experiment

Accurate knowledge of nuclear fragmentation cross-sections is essential for optimizing charged particle therapy. In this study, conducted within the framework of the FOOT (FragmentatiOn Of Target) experiment, we present the first measurements with a large angular acceptance of total charge-changing cross-section and the cross-section for the production of fragments (production cross-section) for $^{16}$O ions interacting with Carbon (C) and Polyethylene (C$_2$H$_4$) targets in the kinetic energy range of 80 to 200 MeV/nucleon. Measurements were performed using the Emulsion Cloud Chamber (ECC) technique, which combines high spatial resolution and angular acceptance, up to 45$^\circ$. The results are compared with Monte Carlo model predictions. Moreover, the total charge-changing and fragment production cross-sections for $^{16}$O on Hydrogen in the same energy range are derived.

nucl-ex↗

arXiv2026

An AI dose engine for fast carbon ion treatment planning

Monte Carlo (MC) simulations provide gold-standard accuracy for carbon ion therapy dose calculations but are computationally intensive. Analytical pencil beam algorithms offer speed but reduced accuracy in heterogeneous tissues. We developed the first AI-based dose engine capable of predicting absorbed dose, the alpha and beta parameters for relative biological effectiveness (RBE)- weighted optimisation in carbon ion therapy, delivering MC-level accuracy with drastically reduced computation time. We extended the transformer-based DoTA model to predict absorbed dose (C-DoTA-d), alpha (C-DoTA-alpha), and beta (C-DoTA-beta), introducing a cross-attention mechanism for alpha and beta to combine dose and energy inputs. The training dataset consisted of ~70,000 pencil beams from 187 head-and-neck patients, with ground-truth values obtained using the GPU-accelerated MC toolkit FRED. Performance was evaluated on an independent test set using gamma pass rate (1%/1 mm), depth-dose, and isodose contour Dice coefficients. MC dropout-based uncertainty analysis was performed. Median gamma pass rates exceeded 98% for all predictions (99.76% for dose, 99.14% for alpha, and 98.74% for beta), with minima above 85% in the most heterogeneous anatomies. The Dice coefficient was 0.95 for 1% isodose contours, with slightly reduced agreement in high-gradient regions. Compared to MC FRED, inference was over 400x faster (0.032 s vs. 14 s per pencil beam) while maintaining accuracy. Uncertainty analysis showed high stability, with mean standard deviations below 0.5% for all models. C-DoTA achieves MC-quality predictions of absorbed dose and RBE model parameters in ~30 milliseconds per beam. Its speed and accuracy support online adaptive planning, paving the way for more effective carbon ion therapy workflows. Future work will expand to additional anatomical sites, beam geometries, and clinical beamlines.

physics.med-ph↗

arXiv2025

Five Years of Clinical Application of independent Monte Carlo-Based Patient-Specific Quality Assurance at the Maastro Proton Therapy Center

At the Maastro Proton Therapy Center in Maastricht, patient-specific quality assurance (PSQA) using an independent GPU-accelerated Monte Carlo (MC) calculation has fully replaced conventional measurements, which are time-consuming and have limited sensitivity to clinically relevant errors. A fully automated and robust pipeline was developed, integrating two clinical workflows based on the fast MC code Fred. The system is fully operational, and automatic verification reports are part of daily clinical practice. The first workflow performs a pre-treatment dose recalculation in Fred using the planning CT and clinical plan. The second uses Fred with machine log files to verify the actually delivered dose. Both generate automatic reports for clinical review. Over five years, this workflow has become part of routine clinical operations, providing robust 3D dosimetric verification in heterogeneous anatomies. So far, Fred has recalculated more than 6000 pre-treatment plans and 3513 log file-based PSQA cases, saving an estimated 4090 hours of QA work. The pipeline identified true negatives and detected two planning-related failures that would have been missed by conventional measurements. No false positives or negatives were observed, confirming high accuracy and reliability. The MC-based PSQA pipeline offers an efficient, sensitive, and clinically meaningful alternative to measurement-based QA in pencil beam scanning proton therapy. By eliminating routine measurements, it saves resources while improving patient safety and treatment quality. Five years of experience confirm that measurement-less MC-based PSQA is a viable and superior approach, providing full 3D verification and early error detection - a practical blueprint for other proton therapy centres.

physics.med-ph↗

arXiv2022

First Simultaneous K$^-$p $\rightarrow (Σ^0/Λ) \, π^0$ Cross Sections Measurements at 98 MeV/c

We report the first simultaneous and independent measurements of the K$^{-}$p $\rightarrow Σ^0 \, π^{0}$ and K$^{-}$p $\rightarrow Λ\, π^{0}$ cross sections around 100 MeV/c kaon momentum. The kaon beam delivered by the DA$Φ$NE collider was exploited to detect K$^-$ absorptions on Hydrogen atoms, populating the gas mixture of the KLOE drift chamber. The precision of the measurements ($σ_{K^- p \rightarrow Σ^0 π^0} = 42.8 \pm 1.5 (stat.) ^{+2.4}_{-2.0}(syst.) \ \mathrm{mb}$ and $σ_{K^- p \rightarrow Λπ^0} = 31.0 \pm 0.5 (stat.) ^{+1.2}_{-1.2}(syst.) \ \mathrm{mb}\,$) is the highest yet obtained in the low kaon momentum regime.

nucl-ex↗

arXiv2020

The FragmentatiOn Of Target Experiment (FOOT) and its DAQ system

The FragmentatiOn Of Target (FOOT) experiment aims to provide precise nuclear cross-section measurements for two different fields: hadrontherapy and radio-protection in space. The main reason is the important role the nuclear fragmentation process plays in both fields, where the health risks caused by radiation are very similar and mainly attributable to the fragmentation process. The FOOT experiment has been developed in such a way that the experimental setup is easily movable and fits the space limitations of the experimental and treatment rooms available in hadrontherapy treatment centers, where most of the data takings are carried out. The Trigger and Data Acquisition system needs to follow the same criteria and it should work in different laboratories and in different conditions. It has been designed to acquire the largest sample size with high accuracy in a controlled and online-monitored environment. The data collected are processed in real-time for quality assessment and are available to the DAQ crew and detector experts during data taking.

physics.ins-det↗

arXiv2019

Investigations on physical and biological range uncertainties in Krakow proton beam therapy centre

Physical and biological range uncertainties limit the clinical potential of Proton Beam Therapy (PBT). In this proceedings, we report on two research projects, which we are conducting in parallel and which both tackle the problem of range uncertainties. One aims at developing software tools and the other at developing detector instrumentation. Regarding the first, we report on our development and pre-clinical application of a GPU-accelerated Monte Carlo (MC) simulation toolkit Fred. Concerning the letter, we report on our investigations of plastic scintillator based PET detectors for particle therapy delivery monitoring. We study the feasibility of Jagiellonian-PET detector technology for proton beam therapy range monitoring by means of MC simulations of the $β^+$ activity induced in a phantom by proton beams and present preliminary results of PET image reconstruction. Using a GPU-accelerated Monte Carlo simulation toolkit Fred and plastic scintillator based PET detectors we aim to improve patient treatment quality with protons.

physics.med-ph↗

arXiv2016

Design of a new tracking device for on-line dose monitor in ion therapy

Charged Particle Therapy is a technique for cancer treatment that exploits hadron beams, mostly protons and carbons. A critical issue is the monitoring of the dose released by the beam to the tumor and to the surrounding tissues. We present the design of a new tracking device for monitoring on-line the dose in ion therapy through the detection of secondary charged particles produced by the beam interactions in the patient tissues. In fact, the charged particle emission shape can be correlated with the spatial dose release and the Bragg peak position. The detector uses the information provided by 12 layers of scintillating fibers followed by a plastic scintillator and a small calorimeter made of a pixelated Lutetium Fine Silicate crystal. Simulations have been performed to evaluate the achievable spatial resolution and a possible application of the device for the monitoring of the dose profile in a real treatment is presented.

physics.med-ph↗

arXiv2016

Secondary radiation measurements for particle therapy applications: prompt photons produced by $^{4}$He, $^{12}$C and $^{16}$O ion beams in a PMMA target

Charged particle beams are used in Particle Therapy (PT) to treat oncological patients due to their selective dose deposition in tissues and to their high biological effect in killing cancer cells with respect to photons and electrons used in conventional radiotherapy. Nowadays, protons and carbon ions are used in PT clinical routine but, recently, the interest on the potential application of helium and oxygen beams is growing due to their reduced multiple scattering inside the body and increased linear energy transfer, relative biological effectiveness and oxygen enhancement ratio. The precision of PT demands for online dose monitoring techniques, crucial to improve the quality assurance of treatments. The beam range confined in the irradiated target can be monitored thanks to the neutral or charged secondary radiation emitted by the interactions of hadron beams with matter. Prompt photons are produced by nuclear de-excitation processes and, at present, different dose monitoring and beam range verification techniques based on the prompt γ detection have been proposed. It is hence of importance to perform the γ yield measurement in therapeutical-like conditions. In this paper we report the yields of prompt photons produced by the interaction of helium, carbon and oxygen ion beams with a PMMA target. The measurements were performed at the Heidelberg Ion-beam Therapy center (HIT) with beams of different energies. A LYSO scintillator has been used as photon detector. The obtained γ yields for $^{12}$C ion beams are compared with results from literature, while no other results from $^{4}$He and $^{16}$O beams have been published yet. A discussion on the expected resolution of a slit camera detector is presented, demonstrating the feasibility of a prompt-γ based monitoring technique for PT treatments using helium, carbon and oxygen ion beams.

physics.med-ph↗

arXiv2015

High granularity tracker based on a Triple-GEM optically read by a CMOS-based camera

The detection of photons produced during the avalanche development in gas chambers has been the subject of detailed studies in the past. The great progresses achieved in last years in the performance of micro-pattern gas detectors on one side and of photo-sensors on the other provide the possibility of making high granularity and very sensitive particle trackers. In this paper, the results obtained with a triple-GEM structure read-out by a CMOS based sensor are described. The use of an He/CF$_4$ (60/40) gas mixture and a detailed optimization of the electric fields made possible to obtain and very high GEM light yield. About 80 photons per primary electron were detected by the sensor resulting in a very good capability of tracking both muons from cosmic rays and electrons from natural radioactivity.

physics.ins-det↗

arXiv2015

Polycrystalline para-terphenyl scintillator adopted in a $β^-$ detecting probe for radio-guided surgery

A radio-guided surgery technique exploiting $β^-$ emitters is under development. It aims at a higher target-to-background activity ratio implying both a smaller radiopharmaceutical activity and the possibility of extending the technique to cases with a large uptake of surrounding healthy organs. Such technique requires a dedicated intraoperative probe detecting $β^-$ radiation. A first prototype has been developed relying on the low density and high light yield of the diphenylbutadiene doped para-therphenyl organic scintillator. The scintillation light produced in a cylindrical crystal, 5 mm in diameter and 3 mm in height, is guided to a photo-multiplier tube by optical fibres. The custom readout electronics is designed to optimize its usage in terms of feedback to the surgeon, portability and remote monitoring of the signal. Tests show that with a radiotracer activity comparable to those administered for diagnostic purposes the developed probe can detect a 0.1 ml cancerous residual of meningioma in a few seconds.

physics.ins-det↗

arXiv2015

An Intraoperative $β^-$ Detecting Probe For Radio-Guided Surgery in Tumour Resection

The development of the $β^-$ based radio-guided surgery aims to extend the technique to those tumours where surgery is the only possible treatment and the assessment of the resection would most profit from the low background around the lesion, as for brain tumours. Feasibility studies on meningioma, glioma, and neuroendocrine tumors already estimated the potentiality of this new treatment. To validate the technique, prototypes of the intraoperative probe required by the technique to detect $β^-$ radiation have been developed. This paper discusses the design details of the device and the tests performed in laboratory. In such tests particular care has to be taken to reproduce the surgical field conditions. The innovative technique to produce specific phantoms and the dedicated testing protocols is described in detail.

physics.med-ph↗

arXiv2014

Towards a Radio-guided Surgery with $β^{-}$ Decays: Uptake of a somatostatin analogue (DOTATOC) in Meningioma and High Grade Glioma

A novel radio guided surgery (RGS) technique for cerebral tumors using $β^{-}$ radiation is being developed. Checking the availability of a radio-tracer that can deliver a $β^{-}$ emitter to the tumor is a fundamental step in the deployment of such technique. This paper reports a study of the uptake of 90Y labeled (DOTATOC) in the meningioma and the high grade glioma (HGG) and a feasibility study of the RGS technique in these cases.

physics.med-ph↗